Matt C. Lewis

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

University of Plymouth

Matt C. Lewis is an author at National Institute of Allergy and Infectious Diseases specializing in antiviral pharmacology, molecular virology, and sars-cov-2 antiviral therapy.

Publications per year

2022–2022

Publications

Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques

Kyle Rosenke, Matt C. Lewis, Friederike Feldmann et al. · JCI Insight · 2022 · 46 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus Macaques

Kyle Rosenke, Matt C. Lewis, Friederike Feldmann et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–2 of 2